MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment
dc.contributor.author | Maly, P. | en_US |
dc.contributor.author | Sundgren, Pia C. | en_US |
dc.contributor.author | Blaesing, Cathy | en_US |
dc.contributor.author | Gomez-Hassan, Diana M. | en_US |
dc.contributor.author | Weybright, P. | en_US |
dc.date.accessioned | 2006-09-11T18:03:20Z | |
dc.date.available | 2006-09-11T18:03:20Z | |
dc.date.issued | 2004-07 | en_US |
dc.identifier.citation | Weybright, P.; Maly, P.; Gomez-Hassan, D.; Blaesing, C.; Sundgren, P. C.; (2004). "MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment." Neuroradiology 46(7): 541-549. <http://hdl.handle.net/2027.42/46664> | en_US |
dc.identifier.issn | 0028-3940 | en_US |
dc.identifier.issn | 1432-1920 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/46664 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15105980&dopt=citation | en_US |
dc.description.abstract | Recurrent contrast-enhancing lesions arising within foci of prior brain neoplasms treated with chemotherapy and/or radiation therapy pose a significant diagnostic dilemma, as they may represent recurrent or residual tumor, treatment-related changes, or a combination of both. Those lesions specifically in the posterior fossa are even more difficult to assess, given the technical limitations of 2D CSI in the infratentorial compartment. We explored the feasibility of 2D-CSI MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in eight consecutive patients who had undergone treatment for posterior fossa or brainstem tumors. Mean Cho/Cr (choline/creatine) ratios obtained by 2D-CSI in recurrent tumor, treatment-related changes, and normal white matter were 2.93, 1.62, and 0.97, respectively, mean Cho/NAA (choline/N-Acetyl aspartate) ratios were 4.34, 1.74, and 0.93, and mean NAA/Cr (N-acetyl aspartate/creatine) ratios were 0.74, 0.92, and 1.26, respectively. In conclusion, also in the posterior fossa, MR spectroscopy is likely to be useful as an adjunct to conventional imaging characteristics in distinguishing recurrent tumor from treatment-related changes, irrespectively of the MRS technique used. In most cases spectra of diagnostic quality can be obtained using 2D-CSI to include coverage of both the lesion and its vicinity. | en_US |
dc.format.extent | 1874000 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag | en_US |
dc.subject.other | Radiation Necrosis | en_US |
dc.subject.other | Medicine | en_US |
dc.subject.other | Posterior Fossa | en_US |
dc.subject.other | 2D-CSI | en_US |
dc.subject.other | Tumor | en_US |
dc.subject.other | MRS | en_US |
dc.subject.other | Brain | en_US |
dc.title | MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Radiology | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Radiology, Neuroradiology Division, University of Michigan Hospitals, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0030, USA | en_US |
dc.contributor.affiliationum | Department of Radiology, Neuroradiology Division, University of Michigan Hospitals, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0030, USA | en_US |
dc.contributor.affiliationum | Department of Radiology, Neuroradiology Division, University of Michigan Hospitals, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0030, USA | en_US |
dc.contributor.affiliationum | Department of Radiology, Neuroradiology Division, University of Michigan Hospitals, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0030, USA | en_US |
dc.contributor.affiliationum | Department of Radiology, Neuroradiology Division, University of Michigan Hospitals, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-0030, USA | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 15105980 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/46664/1/234_2004_Article_1195.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1007/s00234-004-1195-1 | en_US |
dc.identifier.source | Neuroradiology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.